Nova Mentis Announces Change of Directors

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

Red Light Holland Provides Timing for Release of Third Quarter Financial Results and Announces Live Q&A

2 years ago

Red Light Holland will release its financial and operational results for the quarter ended December 31, 2023, prior to the…

Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member

2 years ago

Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that…

Neptune Puts Employees, Including Certain Key Executives, on Mandatory Unpaid Leave of Absence Beginning February 23, 2024

2 years ago

LAVAL, QC / ACCESSWIRE / February 26, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced…

CLS Holdings USA Inc. (“CLSH”) Announces Repayment of $1,526,250 in Principal and Interest Debenture Obligations Along with the Repurchase of 13,274,780 Shares of the Company

2 years ago

LAS VEGAS, NV / ACCESSWIRE / February 26, 2024 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a…

Gilead Sciences and Black HIV/AIDS Awareness Day: Taking Action Toward Meaningful Change

2 years ago

NORTHAMPTON, MA / ACCESSWIRE / February 26, 2024 / This year's theme for National Black HIV/AIDS Awareness Day is "Engage,…

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)

2 years ago

TORONTO, ON / ACCESSWIRE / February 26, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

2 years ago

Bedtime drug being developed by Tonix relieved pain by targeting fibromyalgia's characteristic "non-restorative sleep": Potential for FDA Approval in 2025CHATHAM,…

Avant Restructures Loan Agreements to Extend Term and Decrease Payments

2 years ago

KELOWNA, BC / ACCESSWIRE / February 26, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer…

PolarityTE Announces First Subject Screened in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers

2 years ago

SALT LAKE CITY, Feb. 26, 2024 (GLOBE NEWSWIRE) -- PolarityTE today announced the Screening of the first subject in the Phase…